Vigilant Biosciences Commences Studies of Oral Cancer Test
Vigilant Biosciences has launched patient enrollment for clinical studies of its OncAlert point-of-care qualitative assay in support of its premarket regulatory submission to FDA.
Read MorePosted by Elaine Sanchez Wilson | Jun 26, 2017 | Cancer, Research, Unknown Origin & Other Cancer Types |
Vigilant Biosciences has launched patient enrollment for clinical studies of its OncAlert point-of-care qualitative assay in support of its premarket regulatory submission to FDA.
Read MorePosted by Elaine Sanchez Wilson | Jun 26, 2017 | Coagulation Testing, Hematology & Serology, Library Preparation Systems, Uncategorized |
This month’s issue features a fluid handling device from Tecan, a UV enclosure from Advanced Ultra-Violet Systems, and a molecular panel from BD.
Read MorePosted by Elaine Sanchez Wilson | Jun 13, 2017 | Cancer |
Results from a pilot study demonstrate that the company’s technology is able to identify patients inadequately prepped for colonoscopy with 100% sensitivity and 80% specificity.
Read MorePosted by Elaine Sanchez Wilson | Jun 13, 2017 | Hematology & Serology |
The capillary blood analyzer supports point-of-care testing in primary care settings.
Read MorePosted by Elaine Sanchez Wilson | Jun 6, 2017 | Uncategorized |
The contract will fund the completion of MeMed’s point-of-care platform for distinguishing bacterial from viral infections.
Read More